title: End-stage heart failure with pulmonary hypertension: levosimendan to evaluate for heart transplantation alone versus combined heart-lung transplantation.
authors.forename: Ingram
authors.initials: I
authors.lastname: Schulze-Neick
authors.forename: Yvonne-Christin
authors.initials: YC
authors.lastname: Luther
authors.forename: Peter
authors.initials: P
authors.lastname: Ewert
authors.forename: Hans B
authors.initials: HB
authors.lastname: Lehmkuhl
authors.forename: Roland
authors.initials: R
authors.lastname: Hetzer
authors.forename: Peter E
authors.initials: PE
authors.lastname: Lange
mesh_terms: D000293:Adolescent; D002303:Cardiac Output, Low / Q000150:complications* / Q000175:diagnosis* / Q000601:surgery; D002316:Cardiotonic Agents; D016027:Heart Transplantation; D016041:Heart-Lung Transplantation; D006801:Humans; D006835:Hydrazones; D006976:Hypertension, Pulmonary / Q000150:complications* / Q000175:diagnosis* / Q000601:surgery; D008297:Male; D011724:Pyridazines; D000077464:Simendan
chemical_list: D002316:Cardiotonic Agents; D006835:Hydrazones; D011724:Pyridazines; D000077464:Simendan